BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37498063)

  • 21. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
    Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues.
    Zhang Q; Zheng Q; Yu X; He Y; Guo W
    J Transl Med; 2020 Jun; 18(1):245. PubMed ID: 32571340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BACH1 is transcriptionally inhibited by TET1 in hepatocellular carcinoma in a microRNA-34a-dependent manner to regulate autophagy and inflammation.
    Sun X; Zhu H; Cao R; Zhang J; Wang X
    Pharmacol Res; 2021 Jul; 169():105611. PubMed ID: 33878446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-93-5p knockdown repressed hepatocellular carcinoma progression via increasing ERBB4 and TETs-dependent DNA demethylation.
    Li Y; Wu B; Sun R; Zhao M; Li N
    Autoimmunity; 2021 Dec; 54(8):547-560. PubMed ID: 34435526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptome-Wide 5-Methylcytosine Functional Profiling of Long Non-Coding RNA in Hepatocellular Carcinoma.
    He Y; Shi Q; Zhang Y; Yuan X; Yu Z
    Cancer Manag Res; 2020; 12():6877-6885. PubMed ID: 32801911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization.
    Zou S; Huang Y; Yang Z; Zhang J; Meng M; Zhang Y; Feng J; Sun R; Li W; Wang W; López JG; Fang L
    Clin Transl Med; 2024 Mar; 14(3):e1621. PubMed ID: 38468490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression.
    Cui Y; Lv P; Zhang C
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23749. PubMed ID: 38800929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA m5C methylation orchestrates BLCA progression via macrophage reprogramming.
    Yan D; Xie Y; Huang L; Zhang Y; Gu R; Xie H; Huang X; Luo H
    J Cell Mol Med; 2023 Aug; 27(16):2398-2411. PubMed ID: 37408139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
    Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
    Front Immunol; 2022; 13():914577. PubMed ID: 35757739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct 5-methylcytosine profiles of circular RNA in human hepatocellular carcinoma.
    He Y; Zhang Q; Zheng Q; Yu X; Guo W
    Am J Transl Res; 2020; 12(9):5719-5729. PubMed ID: 33042451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
    Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
    Pathol Res Pract; 2019 May; 215(5):939-945. PubMed ID: 30723051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN.
    Tian QH; Zhang MF; Zeng JS; Luo RG; Wen Y; Chen J; Gan LG; Xiong JP
    J Mol Med (Berl); 2019 Nov; 97(11):1535-1545. PubMed ID: 31463732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene signatures of m5C regulators may predict prognoses of patients with head and neck squamous cell carcinoma.
    Xue M; Shi Q; Zheng L; Li Q; Yang L; Zhang Y
    Am J Transl Res; 2020; 12(10):6841-6852. PubMed ID: 33194076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway.
    He Y; Tao W; Shang C; Qi C; Ji D; Lu W; Chen G
    Int J Exp Pathol; 2021 Jun; 102(3):157-162. PubMed ID: 33993564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m
    Chen YT; Xiang D; Zhao XY; Chu XY
    Hum Cell; 2021 Nov; 34(6):1800-1811. PubMed ID: 34374933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma.
    Wang G; Qu F; Liu S; Zhou J; Wang Y
    Bioengineered; 2021 Dec; 12(1):4841-4855. PubMed ID: 34334108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of NOL1/NOP2/sun domain (Nsun) RNA methyltransferase family genes in early mouse embryogenesis.
    Chi L; Delgado-Olguín P
    Gene Expr Patterns; 2013 Dec; 13(8):319-27. PubMed ID: 23816522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple m
    Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
    BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.